Back
ARK Innovation ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
59
ARKK
ARK Innovation ETF
Last Price:
43.94
Seasonality Move:
1.44%
Sell
44
RARE
Ultragenyx Pharmaceutical
Last Price:
41.54
Seasonality Move:
-0.9%
Buy
59
ARK Innovation ETF (ARKK)
is a Buy
Is ARK Innovation ETF a Buy, Sell or Hold?
- The current ARK Innovation ETF [ARKK] share price is $43.58. The Score for ARKK is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ARKK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARKK Stock Price Chart
What is ARK Innovation ETF's stock price today?
-
The ARK Innovation ETF share price today is $43.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARKK is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $40.50
The current trend is relatively stagnant and RARE is experiencing slight buying pressure.
ARKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 46.53 | Sell |
Chaikin Money Flow: | 2311232 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.15 - 44.55) | Sell |
Bollinger Bands (100): | (43.73 - 49.39) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 49.22 | Sell |
Chaikin Money Flow: | 494801 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.79 - 41.97) | Buy |
Bollinger Bands (100): | (40.81 - 48.79) | Sell |
ARKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.57 | Buy |
20-day SMA: | 43.7 | Sell |
50-day SMA: | 44.06 | Sell |
200-day SMA: | 45.22 | Sell |
8-day EMA: | 43.58 | Sell |
20-day EMA: | 43.84 | Sell |
50-day EMA: | 44.6 | Sell |
200-day EMA: | 45.3 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.2 | Buy |
20-day SMA: | 40.42 | Buy |
50-day SMA: | 41.53 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 39.89 | Buy |
20-day EMA: | 40.39 | Buy |
50-day EMA: | 41.79 | Sell |
200-day EMA: | 43.35 | Sell |
ARK Innovation ETF Earnings Growth & ARKK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
ARK Innovation ETF Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |